Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Bipolar Disorders
Trial Information
An 8 Week, Double-Blind, Placebo-Controlled, Parallel Group, Fixed Dosage Study to Evaluate the Efficacy and Safety of XXXX as Adjunctive Therapy in Adults with Major Depression Associated with Bipolar I Disorder
Patient has a diagnosis of Bipolar I Disorder and is currently experiencing a major dipressive episode.
- has had atleast 1 previous manic or mixed episode
- currently being treated with 1 or 2 of the following drugs: lamotrigine, lithium, olanzapine or valproic acid.
- ages 18 - 65
Patient Exclusion Criteria:
- a history of attention-deficit/hyperactivity disorder (ADHD), eating disorder or obsessive compulsive disorder (OCD)
- patient has a past or present seizure disorder, head trauma that is clincally significant (e.g. Brain damage) or past neurosurgery.
- patient has HIV
Lisa Wilkins
CRI Worldwide
130 White Horse Pike
Clementon, NJ 08021
Phone: 877-993-2583 ext, 213
Fax: 856-566-9701
EMail: lwilkins@criww.com
View Google Map
Research Center Information: CRI Worldwide
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
